Finance

Lists
Why is CNTX up ၂.၆၄%?
Dive Deeper
CNTX:NASDAQ
Context Therapeutics Inc
၀.၃၁ US$
+၂.၆၄%
(+၀.၀၀၇၉) 1D
အောက် ၉, GMT-၄ ၁၂:၂၀:၂၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTX...
Open
၀.၃၀ US$
High
၀.၃၁ US$
Low
၀.၃၀ US$
Mkt. cap
၂.၈၁ ကုဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၂.၃၀ သိန်း
52-wk high
၃.၆၂ US$
52-wk low
၀.၃၀ US$
EPS
-၀.၄၈ US$
Beta
၁.၇၁
Shares outstanding
၉.၁၉ ကုဋေ
No. of employees
၁၅
Open
၀.၃၀ US$
High
၀.၃၁ US$
Low
၀.၃၀ US$
Mkt. cap
၂.၈၁ ကုဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၂.၃၀ သိန်း
52-wk high
၃.၆၂ US$
52-wk low
၀.၃၀ US$
EPS
-၀.၄၈ US$
Beta
၁.၇၁
Shares outstanding
၉.၁၉ ကုဋေ
No. of employees
၁၅
News stories
From web sources and news partners
About Context Therapeutics Inc
CEO-
Employees၁၅
Founded၂၀၁၅
Headquartersဖီလာဒဲလ်ဖီးယားမြို့, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to CNTX in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CNTX in the last 3 months.
Highest
Current ၀.၃၁ US$
၅.၀၀ US$ (+၁,၅၂၉.၂၀%)
Average
၃.၂၀ US$ (+၉၄၂.၆၈%)
Lowest
၂.၀၀ US$ (+၅၅၁.၆၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
၄.၀၀ US$
+၁,၂၀၃.၄%
08/10/2026
Charles Zhu
LifeSci Capital
Hold
Downgraded
၂.၀၀ US$
+၅၅၁.၇%
08/08/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
၃.၀၀ US$
+၈၇၇.၅%
08/06/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
08/06/2026
Boris Peaker
JonesTrading
Buy
Reiterated
၂.၀၀ US$
+၅၅၁.၇%
08/06/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
၅.၀၀ US$
+၁,၅၂၉.၂%
08/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
၇.၀၀ US$
+၂,၁၈၀.၉%
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
၅.၀၀ US$
+၁,၅၂၉.၂%
05/06/2026
Soumit Roy
JonesTrading
Buy
Maintained
၇.၀၀ US$
+၂,၁၈၀.၉%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၈.၇၂ သန်း
၁.၁၈ ကုဋေ
၇.၀၂ သန်း
၁.၂၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၈၉ သန်း
၁.၉၆ သန်း
၂.၃၃ သန်း
၂.၄၄ သန်း
Operating expense
၁.၀၆ ကုဋေ
၁.၃၈ ကုဋေ
၉.၃၄ သန်း
၁.၅၀ ကုဋေ
Total operating expenses
၁.၀၆ ကုဋေ
၁.၃၈ ကုဋေ
၉.၃၄ သန်း
၁.၅၀ ကုဋေ
Operating income
-၁.၀၆ ကုဋေ
-၁.၃၈ ကုဋေ
-၉.၃၄ သန်း
-၁.၅၀ ကုဋေ
Other non operating income
၈.၃၅ သောင်း
၉.၆၆ သောင်း
-
-၉.၆၀ ထောင်
EBT including unusual items
-၉.၆၉ သန်း
-၁.၃၀ ကုဋေ
-၈.၆၈ သန်း
-၁.၄၆ ကုဋေ
EBT excluding unusual items
-၉.၆၉ သန်း
-၁.၃၀ ကုဋေ
-၈.၆၈ သန်း
-၁.၄၆ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၉.၆၉ သန်း
-၁.၃၀ ကုဋေ
-၈.၆၈ သန်း
-၁.၄၆ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၀
-၀.၁၄
-၀.၀၉
-၀.၁၅
Interest and investment income
၈.၃၄ သိန်း
၆.၈၂ သိန်း
၅.၂၀ သိန်း
၄.၁၉ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၈.၃၄ သိန်း
၆.၈၂ သိန်း
၅.၂၀ သိန်း
၄.၁၉ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၆ ကုဋေ
-၁.၃၈ ကုဋေ
-၉.၃၄ သန်း
-၁.၅၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ